Differential Functions of Tumor Necrosis Factor Receptor 1 and 2 Signaling in Ischemia-Mediated Arteriogenesis and Angiogenesis
- 30 November 2006
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 169 (5), 1886-1898
- https://doi.org/10.2353/ajpath.2006.060603
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01HL65978-05, 0440172N)
- American Heart Association (R01HL65978-05, 0440172N)
This publication has 44 references indexed in Scilit:
- Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesisJCI Insight, 2006
- Anti-tumor necrosis factor-α therapies attenuate adaptive arteriogenesis in the rabbitAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- TNFR1‐ and TNFR2‐mediated signaling pathways in human kidney are cell type‐specific and differentially contribute to renal injuryThe FASEB Journal, 2005
- In vivo transfer of soluble TNF‐alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in ratsThe FASEB Journal, 2004
- Etk/Bmx Transactivates Vascular Endothelial Growth Factor 2 and Recruits Phosphatidylinositol 3-Kinase to Mediate the Tumor Necrosis Factor-induced Angiogenic PathwayJournal of Biological Chemistry, 2003
- Rho GTPases in cell biologyNature, 2002
- Selective Activation of Small GTPase RhoA by Tyrosine Kinase Etk through Its Pleckstrin Homology DomainPublished by Elsevier BV ,2002
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999
- Molecular cloning and expression of a receptor for human tumor necrosis factorCell, 1990
- Molecular cloning and expression of the human 55 kd tumor necrosis factor receptorCell, 1990